BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF
383 results:

  • 1. Meningioma: current updates on genetics, classification, and mouse modeling.
    Szulzewsky F; Thirimanne HN; Holland EC
    Ups J Med Sci; 2024; 129():. PubMed ID: 38571886
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Auditory brainstem implants for hearing rehabilitation in nf2-schwannomatosis: A systematic review and single-arm meta-analysis.
    Wang B; Yan M; Liu C; Yang Z; Wang X; Zhao F; Wang Z; Li P; Wang Y; Li S; Liu G; Liu P
    NeuroRehabilitation; 2024; 54(2):213-225. PubMed ID: 38427506
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Imaging as an early biomarker to predict sensitivity to everolimus for progressive nf2-related vestibular schwannoma.
    Nghiemphu PL; Vitte J; Dombi E; Nguyen T; Wagle N; Ishiyama A; Sepahdari AR; Cachia D; Widemann BC; Brackmann DE; Doherty JK; Kalamarides M; Giovannini M
    J Neurooncol; 2024 Apr; 167(2):339-348. PubMed ID: 38372904
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without nf2 mutation.
    Neyazi S; Yamazawa E; Hack K; Tanaka S; Nagae G; Kresbach C; Umeda T; Eckhardt A; Tatsuno K; Pohl L; Hana T; Bockmayr M; Kim P; Dorostkar MM; Takami T; Obrecht D; Takai K; Suwala AK; Komori T; Godbole S; Wefers AK; Otani R; Neumann JE; Higuchi F; Schweizer L; Nakanishi Y; Monoranu CM; Takami H; Engertsberger L; Yamada K; Ruf V; Nomura M; Mohme T; Mukasa A; Herms J; Takayanagi S; Mynarek M; Matsuura R; Lamszus K; Ishii K; Kluwe L; Imai H; von Deimling A; Koike T; Benesch M; Kushihara Y; Snuderl M; Nambu S; Frank S; Omura T; Hagel C; Kugasawa K; Mautner VF; Ichimura K; Rutkowski S; Aburatani H; Saito N; Schüller U
    Acta Neuropathol; 2024 Jan; 147(1):22. PubMed ID: 38265489
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Germline Variants in cancer Predisposition Genes in Pediatric Patients with Central Nervous System Tumors.
    Jovanović A; Tošić N; Marjanović I; Komazec J; Zukić B; Nikitović M; Ilić R; Grujičić D; Janić D; Pavlović S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139220
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. schwannomatosis: a Realm Reborn: year one.
    Planet M; Kalamarides M; Peyre M
    Curr Opin Oncol; 2023 Nov; 35(6):550-557. PubMed ID: 37820090
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Classification and Molecular Diagnosis of Benign brain Tumors].
    Yoshimoto K
    No Shinkei Geka; 2023 Sep; 51(5):771-777. PubMed ID: 37743328
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review.
    Nobee A; Xu M; Seth A; Rong Y
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628996
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Ischemic Cerebellar Stroke in a Young Patient With Neurofibromatosis Type 2: A Case Report.
    Trautman A; Sandhu D
    S D Med; 2023 Apr; 76(4):163-166. PubMed ID: 37566671
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Extremely rare pediatric primary scrotum tumor: spermatic cord hemolymphangioma for a case report and literature review.
    Liu L; Xiao Y; Yue X; Wang Q
    World J Surg Oncol; 2023 Jul; 21(1):226. PubMed ID: 37495989
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic Landscape of Meningiomas.
    Wang JZ; Nassiri F; Mawrin C; Zadeh G
    Adv Exp Med Biol; 2023; 1416():137-158. PubMed ID: 37432625
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents.
    Wagener K; Beckhaus J; Boekhoff S; Friedrich C; Müller HL
    J Neurooncol; 2023 Jul; 163(3):555-563. PubMed ID: 37402092
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Role of Advanced MR Imaging in Diagnosis of Neurological Malignancies: Current Status and Future Perspective.
    Eraky AM; Beck RT; Treffy RW; Aaronson DM; Hedayat H
    J Integr Neurosci; 2023 May; 22(3):73. PubMed ID: 37258452
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical and genomic differences in supratentorial versus infratentorial nf2 mutant meningiomas.
    Tabor JK; O'Brien J; Vasandani S; Vetsa S; Lei H; Jalal MI; Marianayagam NJ; Jin L; Millares Chavez M; Haynes J; Dincer A; Yalcin K; Aguilera SM; Omay SB; Mishra-Gorur K; McGuone D; Morales-Valero SF; Fulbright RK; Gunel M; Erson-Omay EZ; Moliterno J
    J Neurosurg; 2023 Dec; 139(6):1648-1656. PubMed ID: 37243548
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Respective roles of Pik3ca mutations and cyproterone acetate impregnation in mouse meningioma tumorigenesis.
    Cômes PC; Le Van T; Tran S; Huard S; Abi-Jaoude S; Venot Q; Marijon P; Boetto J; Blouin A; Bielle F; Ducos Y; Teranishi Y; Kalamarides M; Peyre M
    Cancer Gene Ther; 2023 Aug; 30(8):1114-1123. PubMed ID: 37188724
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The multiomic landscape of meningiomas: a review and update.
    Wang JZ; Nassiri F; Landry AP; Patil V; Liu J; Aldape K; Gao A; Zadeh G
    J Neurooncol; 2023 Jan; 161(2):405-414. PubMed ID: 36840836
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Surgical Management of Peripheral Nerve Pathology in Patients With Neurofibromatosis Type 2.
    Peyre M; Tran S; Parfait B; Bernat I; Bielle F; Kalamarides M
    Neurosurgery; 2023 Feb; 92(2):317-328. PubMed ID: 36637268
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups.
    Singh J; Sharma R; Shukla N; Narwal P; Katiyar A; Mahajan S; Sahu S; Garg A; Sharma MC; Suri A; Sarkar C; Suri V
    J Neurooncol; 2023 Jan; 161(2):339-356. PubMed ID: 36564673
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genome-wide association analysis identifies a susceptibility locus for sporadic vestibular schwannoma at 9p21.
    Sadler KV; Bowes J; Rowlands CF; Perez-Becerril C; van der Meer CM; King AT; Rutherford SA; Pathmanaban ON; Hammerbeck-Ward C; Lloyd SKW; Freeman SR; Williams R; Hannan CJ; Lewis D; Eyre S; Evans DG; Smith MJ
    Brain; 2023 Jul; 146(7):2861-2868. PubMed ID: 36546557
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes.
    Ren L; Hua L; Deng J; Cheng H; Wang D; Chen J; Xie Q; Wakimoto H; Gong Y
    Neurosurgery; 2023 Apr; 92(4):745-755. PubMed ID: 36512828
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 20.